On ECHEMI
Home > Drugs > Jinzhou Jiutai Pharmaceutical Co., Ltd.
Jinzhou Jiutai Pharmaceutical Co., Ltd.
  • Founded in:

    1998-09-02
  • Country:

    China China
  • Address:

    No. 41, Tai'anli, Taihe District, Jinzhou City, Liaoning Province
  • Tax NO.:

    91210700242034190P
  • Registered Funds:

    40.986462 million yuan
  • Website:

  • Email:

Related Drugs
Cisplatin for injection
Cisplatin.
Name Description Content CAS NO. Registered Holders
Cisplatin

Platinum metal complex, acts like an alkylating agent, with DNA as its main target, acting on the cross-links between DNA chains and within the chains, forming DDP-DNA complexes, interfering with DNA replication, or binding to nuclear and cytoplasmic proteins. It is a non-specific drug for cycles.

More

Platinum metal complex, acts like an alkylating agent, with DNA as its main target, acting on the cross-links between DNA chains and within the chains, forming DDP-DNA complexes, interfering with DNA replication, or binding to nuclear and cytoplasmic proteins. It is a non-specific drug for cycles.

15663-27-1 30
Azithromycin Fumarate Capsules
The main ingredient of this product is azithromycin fumarate, its chemical name: 9-deoxy-9α-aza-9α-methyl-9α-erythromycin A fumarate chemical structure is as follows: Molecular formula: C38H72N2O12·C4H4O4 Molecular weight: 865.06
Name Description Content CAS NO. Registered Holders
AzithroMycin FuMarate

It inhibits bacterial protein synthesis by hindering bacterial transpeptidation process. It is effective against many common pathogens, including Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, sexually transmitted disease microorganisms and other microorganisms.

More

It inhibits bacterial protein synthesis by hindering bacterial transpeptidation process. It is effective against many common pathogens, including Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, sexually transmitted disease microorganisms and other microorganisms.

0
Ligustrazine Phosphate and Sodium Chloride Injection
Ligustrazine phosphate
Name Description Content CAS NO. Registered Holders
LigustrazinePhosphate

It has the effects of anti-platelet aggregation, dilation of arterioles, and improvement of microcirculation. Animal experiment results show that this product is non-irritating, non-allergic, and non-hemolytic.

More

It has the effects of anti-platelet aggregation, dilation of arterioles, and improvement of microcirculation. Animal experiment results show that this product is non-irritating, non-allergic, and non-hemolytic.

848645-86-3 6
Ligustrazine Phosphate and Sodium Chloride Injection
Ligustrazine phosphate
Name Description Content CAS NO. Registered Holders
LigustrazinePhosphate

It has the effects of anti-platelet aggregation, dilation of arterioles, and improvement of microcirculation. Animal experiment results show that this product is non-irritating, non-allergic, and non-hemolytic.

More

It has the effects of anti-platelet aggregation, dilation of arterioles, and improvement of microcirculation. Animal experiment results show that this product is non-irritating, non-allergic, and non-hemolytic.

848645-86-3 6
Tobramycin Sulfate Sodium Chloride Injection
The main ingredient of this product is tobramycin. Its chemical name is 0-3-amino-3-deoxy-α-D-glucopyranosyl-(1→4)-0-[2,6-dioxy-2,3,6-trideoxy-α-D-ribosyl-hexopyranosyl-(1→6)]-2-deoxy-L-streptamine. Its chemical structure is: Molecular formula: C18H37N5O9 Molecular weight: 467.52 Auxiliary materials are sodium chloride and sulfuric acid.
Name Description Content CAS NO. Registered Holders
Tobramycin

This product belongs to the aminoglycoside antibiotics, and its antibacterial spectrum is similar to that of gentamicin. It has antibacterial effects on a variety of Gram-negative bacteria, and its antibacterial effect on Pseudomonas aeruginosa is 3 to 5 times stronger than that of gentamicin. Its mechanism of action is to bind to the 30S subunit of the bacterial ribosome and inhibit the synthesis of bacterial proteins.

More

This product belongs to the aminoglycoside antibiotics, and its antibacterial spectrum is similar to that of gentamicin. It has antibacterial effects on a variety of Gram-negative bacteria, and its antibacterial effect on Pseudomonas aeruginosa is 3 to 5 times stronger than that of gentamicin. Its mechanism of action is to bind to the 30S subunit of the bacterial ribosome and inhibit the synthesis of bacterial proteins.

32986-56-4 12
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.